Docking Studies on Diabetes Targets: \u03b1-Glucosidase, DPP-4, PPAR-\u03b3
By BioDockify Computational Research Team · September 22, 2026 · Disease Applications
Diabetes docking targets explained — α-glucosidase (acarbose control), DPP-4 (sitagliptin), PPAR-γ, aldose reductase — PDB IDs, controls, natural compounds to screen, and full workflow.
Read the complete article with tables, code and references on BioDockify.
Key References
- Tagami, T. et al. Structural comparison of DPP-4 inhibitors. Bioorg. Med. Chem. (2016).
- Ferreira, L.G. et al. Molecular docking and structure-based drug design strategies. Molecules 20, 13384-13421 (2015).
Scope & Limitations
In-silico results are hypotheses for antidiabetic screening, not efficacy claims